Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism.
Erin GoodeHolly MillerDana SalzbergCourtney CampbellKristen BeebeCharlotte SchwalbachRoberta H AdamsAlexander NgwubePublished in: Pediatric hematology and oncology (2021)